NICE cancelled this evaluation because there was a medical device alert which covered the intended use. This has since been withdrawn.
| Status | Discontinued |
| Decision | Selected |
| Process | MTG |
| ID number | 336 |
Project Team
| Project lead | N/A |
Email enquiries
- If you have any queries please email medtech@nice.org.uk
Stakeholders
| External assessment group | Kings Health Partners |
| Manufacturers | Medtronic UK |
| Manufacturers of related technologies not included in scope | Boston Scientific |
| Terumo | |
| Others | Department for Health and Social Care (DHSC) |
| Healthcare Improvement Scotland (HIS) | |
| Johnson & Johnson Medical Ltd | |
| Medicines and Healthcare Products Regulatory Agency (MHRA) | |
| NHS England (NHSE) | |
| Professional groups | Association of British Healthcare Industries (ABHI) |
| Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM) | |
| British Society of Endovascular Therapy (BSET) | |
| British Society of Interventional Radiology (BSIR) | |
| Devices for Dignity | |
| Medical Technology Group | |
| Royal College of Physicians (RCP) | |
| The British In Vitro Diagnostics Association (BIVDA) | |
| Vascular Society |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 23 May 2024 | Discontinued. NICE cancelled this evaluation because there was a medical device alert which covered the intended use. This has since been withdrawn. |
| 19 March 2019 | The MHRA has established an Expert Advisory Group to review Paclitaxel drug-coated balloon catheters and drug-eluting stents which are used to treat patients with peripheral arterial disease. NICE will resume the evaluation after this work has concluded. Please contact medtech@nice.org.uk if you have any queries. |
| 25 October 2018 | NICE has become aware of new potentially relevant evidence for this technology and has taken the decision to pause the evaluation until its significance can be assessed. The NICE website will be updated with an updated publication date in due course. |
| 20 July 2018 | Committee meeting: 3 |
| 23 May 2018 - 21 June 2018 | Draft guidance |
| 23 March 2018 | Committee meeting: 2 |
| 16 February 2018 | Committee meeting: 1 |
| 20 September 2017 | Scope published |
| 21 August 2017 | Stakeholder registration opens |
For further information on our processes and methods, please see our CHTE processes and methods manual